Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Thorac Surg Clin. 2017 Aug;27(3):227–244. doi: 10.1016/j.thorsurg.2017.04.001

Table 4.

Intraoperative Quality Measures Specific to Clinical Stage IIIA (N2-N3, M0) NSCLC 20, 61

Intraoperative Measures
Category Quality Metric Recommended By Evidence grade
Anatomic Resection Pneumonectomy is ill-advised after neoadjuvant therapy NCCN 2A
Mediastinal Assessment if confirm suspected N2 disease Abort operation ACCP 2C
Mediastinal Assessment if find occult N2 disease If complete resection of primary tumor is feasible, perform mediastinal lymph node dissection or systematic sampling ACCP 2C

American College of Chest Physicians (ACCP), National Comprehensive Cancer Network (NCCN)

Data from NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer (National Comprehensive Cancer Network). 2017. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed March 29, 2017; and Ramnath N, Dilling TJ, Harris LJ, et al. Treatment of Stage III Non-small Cell Lung Cancer. Chest. 2013;143(5):e314S–e340S. doi:10.1378/chest.12-2360.